Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 862189-95-5, Mirodenafil [inn], Sk3530, Sk-3530, Sk3530 free base, Sk-3530 free base
Molecular Formula
C26H37N5O5S
Molecular Weight
531.7  g/mol
InChI Key
MIJFNYMSCFYZNY-UHFFFAOYSA-N
FDA UNII
504G362H0H

Mirodenafil has been used in trials studying the treatment and supportive care of Kidney Diseases, Urologic Diseases, Renal Insufficiency, Erectile Dysfunction, and Male Erectile Dysfunction.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-ethyl-2-[5-[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl-2-propoxyphenyl]-7-propyl-3H-pyrrolo[3,2-d]pyrimidin-4-one
2.1.2 InChI
InChI=1S/C26H37N5O5S/c1-4-7-19-18-30(6-3)24-23(19)27-25(28-26(24)33)21-17-20(8-9-22(21)36-16-5-2)37(34,35)31-12-10-29(11-13-31)14-15-32/h8-9,17-18,32H,4-7,10-16H2,1-3H3,(H,27,28,33)
2.1.3 InChI Key
MIJFNYMSCFYZNY-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCCC1=CN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CCO)OCCC)CC
2.2 Other Identifiers
2.2.1 UNII
504G362H0H
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 5-ethyl-2-(5-(4-(2-hydroxyethyl)piperazine-1-sulfonyl)-2-propoxyphenyl)-7-propyl-3,5-dihydro-4h-pyrrolo(3,2-d)pyrimidin-4-one

2.3.2 Depositor-Supplied Synonyms

1. 862189-95-5

2. Mirodenafil [inn]

3. Sk3530

4. Sk-3530

5. Sk3530 Free Base

6. Sk-3530 Free Base

7. Mvix

8. 504g362h0h

9. 5-ethyl-2-[5-[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl-2-propoxyphenyl]-7-propyl-1h-pyrrolo[3,2-d]pyrimidin-4-one

10. 5-ethyl-2-[5-[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl-2-propoxyphenyl]-7-propyl-3h-pyrrolo[3,2-d]pyrimidin-4-one

11. Mirodenafilo

12. Mirodenafilum

13. Unii-504g362h0h

14. 5-ethyl-2-(5-((4-(2-hydroxyethyl)piperazin-1-yl)sulfonyl)-2-propoxyphenyl)-7-propyl-3,5-dihydro-4h-pyrrolo(3,2-d)pyrimidin-4-one

15. 5-ethyl-2-(5-{[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl}-2-propoxyphenyl)-7-propyl-3,5-dihydro-4h-pyrrolo[3,2-d]pyrimidin-4-one

16. 862189-96-6

17. Mirodenafil [inci]

18. Mirodenafil [who-dd]

19. Schembl3845775

20. Chembl4297518

21. Schembl15481149

22. Gtpl11738

23. Dtxsid50881265

24. Chebi:136049

25. Bcp07740

26. Ex-a5487

27. Sk3530sk3530

28. Zinc35077050

29. Db11792

30. Ncgc00378703-02

31. Hy-14930

32. Ft-0672413

33. Ft-0699556

34. 189m955

35. A914996

36. Q6873840

37. 5-ethyl-2-(5-(4-(2-hydroxyethyl)piperazine-1-sulfonyl)-2-propoxyphenyl)-7-propyl-3,5-dihydro-4h-pyrrolo(3,2-d)pyrimidin-4-one

38. 5-ethyl-2-{5-[4-(2-hydroxyethyl)piperazin-1-ylsulfonyl]-2-n-propoxyphenyl}-7-n-propyl-3,5-dihydro-4h-pyrrolo[3,2-d]pyrimidin-4-one

2.4 Create Date
2019-01-15
3 Chemical and Physical Properties
Molecular Weight 531.7 g/mol
Molecular Formula C26H37N5O5S
XLogP32.2
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count8
Rotatable Bond Count11
Exact Mass531.25154047 g/mol
Monoisotopic Mass531.25154047 g/mol
Topological Polar Surface Area125 Ų
Heavy Atom Count37
Formal Charge0
Complexity902
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Phosphodiesterase 5 Inhibitors

Compounds that specifically inhibit PHOSPHODIESTERASE 5. (See all compounds classified as Phosphodiesterase 5 Inhibitors.)